CCTV News:On October 27th, the Ministry of Ecology and Environment released the 2022 Annual Report on China’s Policies and Actions to Address Climate Change. According to the report, since 2021, China has actively implemented the Paris Agreement, vigorously and orderly promoted various key tasks around peak carbon dioxide emissions’s carbon neutrality goal, and achieved remarkable results.

　　At present, China has established the "1+N" policy system of carbon neutrality in peak carbon dioxide emissions, formulated the medium and long-term greenhouse gas emission control strategy, promoted the construction of the national carbon emission trading market, and worked out and implemented the national climate change adaptation strategy.

　　According to preliminary accounting, in 2021, the carbon dioxide emission per unit GDP in China will be 3.8% lower than that in 2020 and 50.8% lower than that in 2005. Non-fossil energy accounts for 16.6% of primary energy consumption, and the total installed capacity of wind power and solar power generation will reach 635 million kilowatts, which will significantly reduce the coal consumption per unit GDP, and the forest coverage rate and stock volume will achieve "double growth" for 30 consecutive years. On the first anniversary of the launch of the national carbon emission trading market, the cumulative turnover of carbon emission quotas in the carbon market was 194 million tons, with a cumulative turnover of 8.492 billion yuan.

　　It is estimated that by 2030, the carbon dioxide emission per unit GDP in China will be reduced by more than 65% compared with that in 2005, the proportion of non-fossil energy in primary energy consumption will reach about 25%, the forest stock will increase by 6 billion cubic meters compared with that in 2005, and the total installed capacity of wind power and solar power will reach more than 1.2 billion kilowatts.

　　As a giant heparin producer, () (SH603707, stock price 11 yuan, market value 17.77 billion yuan) once had a market value of more than 50 billion yuan at its peak, but at present its market value is only about 17.8 billion yuan, and the market value exceeding 30 billion yuan has disappeared in recent years.

　　In the 2023 annual report of Jianyou Co., Ltd., the total amount of monetary funds deposited abroad was 158 million yuan, but the company checked "Not applicable" for overseas assets in the annual report.

　　Such an inconspicuous detail error was keenly captured by the Shanghai Stock Exchange. In the "Regulatory Work Letter", the Shanghai Stock Exchange asked the company "the reasons for the differences before and after the disclosure of overseas assets in the annual report".

　　In fact, the overall export volume of heparin industry has been declining since 2020. Jianyou Co., Ltd. is also seeking transformation, and has acquired Meitheal Pharmaceuticals, Inc (hereinafter referred to as Meithail), an American pharmaceutical company, to expand the pharmaceutical business in the American market.

　　In 2019, Jianyou completed the consolidation of Meitheal. Meitheal is an important overseas asset of Jianyou, and it is also one of the sources of information disclosure errors in the above-mentioned annual report.

　　However, from 2019 to 2023, Meitheal lost more and earned less, with a cumulative net loss of about 100 million yuan. During the period, Meitheal also recalled the products under its name due to the wrong labeling of drug names. Recently, the public information of FDA (US Food and Drug Administration) shows that the status of several drug approvals under Meitheal’s name is "discontinued".

　　Looking back now, it is quite unreasonable for Jianyou to acquire Meitheal in some places. Including Jianyou shares had provided loans to Meitheal before its acquisition, Meitheal’s net assets were negative when it was acquired, and Meitheal’s equity was actually "exported to domestic market".

　　Image source: The reporter made drawings based on public information such as the announcement of Jianyou shares, () announcement, Sino Medical Announcement, Yuandong Biological Announcement and China Foundation Association.

　　Before Jianyou shares increased the capital of Meitheal, the original shareholder of Meitheal was a company registered in Cayman Islands. Who was the controller behind this company? Jianyou shares were not disclosed, but only expressed as "no relationship" with Jianyou shares.

　　According to the investigation by the reporter of national business daily, one of the original controllers of Meitheal emerged, that is, Zhao Jin, the former supervisor of Jianyou.

　　Meitheal was supported by Jianyou’s share loan.

　　In August 2019, Jianyou Co., Ltd. issued a foreign investment announcement, and the company increased its capital by about 95 million US dollars to obtain 83.33% equity of Meitheal83.33%

　　Jianyou Co., Ltd. said that investing in its own localized R&D, sales, quality and registration team is crucial for the company to vigorously develop the high value-added generic drug market in the United States.

　　According to the announcement, Meitheal was established in December 2016. It is a professional pharmaceutical company headquartered in Chicago, Illinois, USA, focusing on developing, manufacturing, purchasing and selling injectable drugs, which are mainly sold throughout North America. Meitheal mainly focuses on generic injections, providing customers with lower-cost brand-name drug substitutes when the patents have expired, been declared invalid or are determined not to infringe others’ patents. Meitheal has a wide range of products covering anti-infection, tumor lysis and intensive care indications, and has various presentation forms such as single-dose and multi-dose vials, ready-to-use prefilled syringes and premixed bags.

　　Image source: screenshot of Jianyou shares announcement

　　According to the disclosure of Jianyou, the original shareholders of Meitheal were LYFE Charles Limited (hereinafter referred to as LYFE) and Thomas Shea, holding 99.96% and 0.04% respectively. According to the announcement, LYFE is registered in Cayman Islands with a registered capital of 50,000 US dollars. And Mr. Thomas Shea is the CEO of Meitheal.

　　Image source: screenshot of Jianyou shares announcement

　　It is worth noting that the owner’s equity of Meitheal was even negative at that time, which was-10.17 million US dollars by the end of June 2019.

　　It is also worth noting that before the above capital increase, Jianyou shares had provided loans to Meitheal. Jianyou shares said: "Before this transaction, the target company was solely funded by LYFE, and the company provided it with a loan."

　　Image source: screenshot of Jianyou shares announcement

　　LYFE contributed $11.5 million to Meitheal in January 2017. Subsequently, LYFE did not invest any more money. Instead, Hong Kong Jianyou Industrial Co., Ltd. (hereinafter referred to as Hong Kong Jianyou), a subsidiary of Jianyou Co., Ltd., provided Meitheal with a loan of about $23 million.

　　Jianyou shares disclosed that LYFE and Thomas Shea are not related to the company in terms of property rights, business, assets, creditor’s rights and debts, and personnel.

　　Who is the actual controller of LYFE registered in Cayman Islands? Meitheal was established with a capital of more than 10 million dollars, but it was able to obtain the loan of Jianyou shares in difficult times, and then it was able to obtain the investment of Jianyou shares.

　　Jianyou shares only disclosed in its announcement that 100% shareholders of LYFE are Lyfe Capital Fund II, L.P., but did not disclose the shareholders and actual controllers behind Lyfe Capital Fund II, L.P.. With the deepening of the reporter’s investigation, the real controller behind LYFE Capital Fund II, L.P surfaced.

　　It has accumulated a loss of 100 million yuan in five years, and there have been drug recalls in the United States.

　　From 2019 to 2021, Meitheal realized operating income of about 800 million yuan, 690 million yuan and 1.04 billion yuan respectively, and realized net profit of about 7,696,600 yuan,-56.32 million yuan and 27.371 million yuan respectively.

　　Just after Meitheal realized a profit of more than 27 million yuan, in July 2022, Jianyou announced that after Hong Kong Jianyou bought 16.66% equity of Meit Heal held by LYFE with $21 million in cash, Hong Kong Jianyou would hold 99.99% equity of Meitheal16.66%

　　Image source: The reporter made drawings according to the announcement of Jianyou shares.

　　"After the company acquired Meitheal, a local American company, in October 2019, combined with Meitheal’s advantages in GPO and channel, the company’s business continued to expand in the US market and its market share continued to expand. In 2020 and 2021, Meitheal’s operating income increased substantially, and it was profitable in 2021. " Jianyou shares said.

　　Obviously, the reason for this operation is that Jianyou shares are very optimistic about the development of Meitheal. However, after Jianyou shares were consolidated with Meitheal, from the financial performance, Meitheal’s profit was true.

　　Just after the completion of the above minority acquisition, Meitheal lost nearly 80 million yuan in 2022. Throughout 2019 to 2023, Meitheal was in a state of losing more and earning less, with a cumulative loss of about 100 million yuan in five years.

　　According to the 2022 annual report of Jianyou Co., Ltd., Meitheal holds a total of 40 FDA-approved drug approvals.

　　According to the reporter’s inquiry, the latest FDA approval shows that five of the above 40 drug approvals are in discontinued market status, namely ANDA211003 calcium levofolinate injection, ANDA077096 carboplatin injection, ANDA206190 cytarabine injection, ANDA201166 Topotecan hydrochloride injection and ANDA206189 cytarabine injection.

　　Image source: FDA official website screenshot

　　It is worth noting that Meitheal once had a drug recall in the United States. According to the FDA official website, in January, 2021, Meitheal recalled the drug due to an error in the drug label.

　　Image source: FDA official website screenshot

　　According to official website information of FDA, Meitheal announced that it voluntarily recalled a batch of Cisatracurium Besylate (atracurium benzenesulfonate) injection. The decision to recall the product was made after receiving a product complaint. The complaint showed that a part of the carton with batch number C11507A was labeled with Cisatracurium Besylate injection, with 10 bottles in each box, of which 10 bottles were wrongly labeled as Phenylephrine Hydrochloride (phenylephrine hydrochloride) injection.

　　In this regard, the reporter of national business daily sent an Interview Letter to Jianyou Co., Ltd. on the reasons for the suspension of the above-mentioned drugs and the reasons for the drug recall. Jianyou shares replied to the interview that the company formulated different product strategies according to different markets. Product strategies will be different in different markets in different periods. The product update iteration in the pharmaceutical market is very normal, and there are countless such cases in major pharmaceutical companies in the United States, such as PFIZER and SANDOZ. At the same time, Jianyou shares also provided reporters with screenshots of recent discontinued products of PFIZER and SANDOZ.

　　Regarding the drug recall, Jianyou Co., Ltd. said: "The company did have this recall. The specific recall situation and reasons can be found on the official website of the US FDA. The incident is not important and did not meet the disclosure standards."

　　Meitheal’s shareholders are actually "exporting to domestic sales"

　　"Through the acquisition of Meitheal, the company’s R&D products can carry out marketing and order acquisition in advance in the R&D stage, so that the company’s products can complete the preparatory work for listing and sales more quickly, and expand the profit period and space." Jianyou Co., Ltd. once described the reason for investing in Meitheal when it first increased its capital.

　　However, as a matter of fact, Meitheal didn’t bring profit expansion to Jianyou, on the contrary, it also caused a big loss.

　　Image source: The reporter made drawings according to the announcement of Jianyou shares.

　　As for LYFE, the original shareholder of Meitheal, Jianyou shares only disclosed that its shareholder was Lyfe Capital Fund II, and L.P. was gone.

　　It is worth noting that the main body of LYFE Capital’s WeChat WeChat official account is Zhouling Private Equity Fund Management (Shanghai) Co., Ltd. (hereinafter referred to as Zhouling Private Equity). Meitheal is listed as one of the projects invested by Zhouling Private Equity official website.

　　Image source: Zhouling Private Equity official website screenshot

　　Zhouling Private Equity was established in April 2015, and its legal representative is Zhao Jin. According to the relevant resume published by China Fund Industry Association, Zhao Jin once worked for Morit Group, Weiwu Capital and other companies.

　　Image source: screenshot of China Fund Industry Association

　　The reporter noticed that Sino Medical (SH688108, share price of 8.46 yuan, market value of 3.5 billion yuan) also involved in the IPO process related to the upper-level equity structure of LYFE Capital Fund II, L.P, which provided an answer to solve this problem.

　　At that time, the exchange asked whether the equity of the transferee issuer, such as Sino Medical, LYFE Capital set up by Jifeng Capital, a domestic investment institution, was in compliance with foreign exchange management laws and regulations, and whether there was a potential risk that the issuer would bear civil and criminal liability or be punished by administrative punishment.

　　In September 2019, when Sano Medical responded to the inquiry, it said that according to the information provided by LYFE Capital, as of the date of issuing the reply report, the limited partners of LYFE Capital Fund II, L.P were mainly overseas professional parent funds, management parent funds, family funds, insurance funds and equity investment funds.

　　Image source: screenshot of Sino Medical Announcement

　　The upper level of LYFE Capital Fund II, L.P includes limited partners and general partners, and who are these limited partners behind the scenes is not disclosed by Sino Medical.

　　However, for the general partner, Sino Medical has given a clear shareholding path. The general partner of LYFE Capital Fund II, L.P is Lyfe Capital Management Limited (BVI), and this company is 100% controlled by Shanghai Jirong Investment Consulting Partnership (Limited Partnership), and the general partner of Shanghai Jirong is Jiaxing Jifeng Equity Investment Management Co., Ltd. (hereinafter referred to as Jiaxing Jifeng). Natural persons Zhao Jin and Yu Zhengkun jointly controlled Jirong in Shanghai and Jifeng in Jiaxing.

　　In other words, in that year, China enterprises actually controlled Meitheal, and the actual controllers behind them were Zhao Jin and Yu Zhengkun. Jianyou’s investment in Meitheal is similar to the operation method of "exporting to domestic sales".

　　One of the original actual controllers of Meitheal is a former supervisor of Jianyou.

　　From the common sense, the financial strength, medical industry experience and management ability of Jianyou shares are better than that of a private investment fund. Then, why did Jianyou lend money to Meitheal, and then spent a lot of money to buy it, instead of directly operating and setting up an American subsidiary?

　　According to the reporter’s investigation, many evidences show that Zhao Jin, one of the actual controllers of LYFE Capital Fund II, L.P, used to be the supervisor of Jianyou.

　　According to the prospectus of Jianyou Co., Ltd. (the declaration draft was submitted on March 15th, 2016), there was a supervisor named Zhao Jin within the reporting period. According to the introduction of Jianyou Co., Ltd., its former supervisor Zhao Jin was nominated by Weiwu (Chengdu) Biotechnology Venture Capital Co., Ltd. [hereinafter referred to as Weiwu (Chengdu)].

　　In August 2015, Jianyou Co., Ltd. held an extraordinary general meeting of shareholders, and Zhao Jin no longer served as the supervisor of Jianyou Co., Ltd..

　　According to the prospectus of Jianyou, its former supervisor, Zhao Jin, is also a director of Hanerxi (Beijing) Technology Co., Ltd. and Shanghai Jingfeng Pharmaceutical Co., Ltd.. In addition to this information, Jianyou shares did not introduce the former supervisor in detail.

　　Image source: screenshot of Jianyou shares prospectus

　　According to Jianyou, JEF, Generic and Weiwei (Chengdu) are funds managed by VIVO Ventures, holding 3.0007%, 2.2506% and 0.2813% of the total share capital of Jianyou respectively. JEF, Generic and Weiwu (Chengdu) managed by VIVO Ventures hold 5.5326% of the shares of Jianyou.

　　Image source: screenshot of Jianyou shares prospectus

　　It is worth noting that the Chinese translation of VIVO Ventures is Weiwu Venture Capital.

　　At that time, Shanghai Jingfeng Pharmaceutical Co., Ltd., the enterprise of which Zhao Jin was a director, is now called Shanghai Jingfeng Pharmaceutical Co., Ltd., which is a subsidiary of listed company *ST Jingfeng (SZ000908, share price 1.18 yuan, market value 1.038 billion yuan). According to the announcement of *ST Jingfeng, Zhao Jin used to be a consultant of Morit, and now he is the managing partner of Vivo Ventures, and he is the supervisor of Jianyou Co., Ltd., and the chairman of Hanerxi (Beijing) Technology Co., Ltd.

　　According to the resume of Zhouling Private Equity Zhao Jin disclosed by the Fund Industry Association, Zhao Jin also worked as a senior consultant in Molit Group and a managing partner in Weiwu Capital. Then, is it a coincidence that Zhao Jin disclosed by *ST Jingfeng worked in Molit and Vivo Ventures and that Zhao Jin disclosed by China Fund Industry Association worked in Molit Group and Weiwu Capital?

　　Image source: *ST Jingfeng announcement screenshot

　　On the other hand, Zhao Jin disclosed by *ST Jingfeng was the chairman of Hanerchi (Beijing) Technology Co., Ltd., which provided important clues.

　　In April 2019, Yuandong Bio (SH688513, share price of 30.5 yuan, market value of 5.384 billion yuan) was disclosed in its prospectus, and its director Zhao Jin also served as the chairman of Hanerxi (Beijing) Technology Co., Ltd. At the same time, Yuandong Bio provided a detailed resume of Zhao Jin, and Zhao Jin has worked in many companies. Among them, in Jiaxing Jifeng, Zhao Jin holds 50% of the shares and serves as executive director and manager; In Shanghai Jirong, Zhao Jin holds 40% of the property and acts as the appointed representative of the executive partner.

　　Image source: Screenshot of Yuandong Biological Announcement

　　At this point, the answer is clear. Zhao Jin, the former supervisor of Jianyou Co., Ltd., is one of the original actual controllers of Meitheal.

　　As to who is the ultimate actual controller of LYFE, Jianyou Company stated in an interview letter to the reporter of national business daily that according to the announcement of Jianyou Company’s Foreign Investment in 2019 (announcementNo.: 2019-055), the shareholder of LYFE is LYFE Capital Fund II, L.P, which holds 100% equity of Lyfe. According to the public information on the Internet, LYFE Capital Fund II, L.P belongs to LYFE CAPITAL, and its founder and managing partner is Zhao Jin. Therefore, the ultimate actual controller of LYFE is Zhao Jin.

　　Regarding the question "Is Zhao Jin, your supervisor in Si Qian, one of the former actual controllers of Meitheal?" asked in the Interview Letter. If so, did any other directors of your company participate in Meitheal’s previous shareholding? If not, can your company provide corresponding reasons? " Jianyou shares replied: "Zhao Jin, the former supervisor of the company, was appointed by VIVO, an early shareholder of the company (at that time, Zhao Jin was a global partner of VIVO), and Zhao Jin became a director of Meitheal as a global partner of LYFE. There are no other directors in the company who participate in Meitheal’s shareholding. "

　　In addition, the reporter also issued an "Interview Letter" to Zhouling Private Equity on related issues, but as of press time, no response was received from the other party.

　　To sort out the timeline, the operations of Jianyou and Zhao Jin about Meitheal are as follows:

　　In April 2015, Zhouling Private Equity was established, with Zhao Jin as the legal representative.

　　In August 2015, Zhao Jin ceased to be the supervisor of Jianyou.

　　In December 2016, Meitheal was established, and Zhao Jin, as one of the actual controllers, was controlled by Lyfe (registered capital of US$ 50,000) which was finally established in Cayman Islands through a number of companies.

　　In January 2017, LYFE contributed $11.5 million to Meitheal.

　　From 2018 to the first half of 2019, Jianyou shares borrowed $23 million from Meitheal.

　　In October 2019, Jianyou Co., Ltd. increased its capital by about US$ 100 million to obtain 83.33% equity.

　　In 2021, Meitheal achieved a profit of 27.371 million yuan.

　　In the second half of 2022, Jianyou shares purchased 16.66% equity of Meit Heal held by LYFE in cash of 21 million US dollars.

　　In 2022, Meitheal lost nearly 80 million yuan.

　　In 2023, Meitheal lost RMB 2,538,200.

Article 22 An invention or utility model for which a patent right is granted shall be novel, creative and practical.
Novelty means that no identical invention or utility model has been published in domestic and foreign publications, used in China or known to the public in other ways before the application date, and no identical invention or utility model has been applied to the patent administration department of the State Council by others and recorded in the patent application documents published after the application date.
Creativity means that compared with the existing technology before the filing date, the invention has outstanding substantive features and remarkable progress, and the utility model has substantive features and progress.
Practicality means that the invention or utility model can be manufactured or used and can produce positive effects.
[Interpretation] This article provides the essential requirements for inventions and utility models for which patents are granted.
1. According to the provisions of this article, inventions and utility models granted patent rights must be novel, creative and practical, which is commonly called the "three characteristics" of patents. This is a norm generally adopted by patent laws in various countries, and it is also a norm confirmed by the Agreement on Trade-related Aspects of Intellectual Property Rights (TRIPS) of the World Trade Organization.
Second, the second paragraph of this article defines the meaning of "novelty", that is, no identical invention or utility model has been published in domestic and foreign publications before the filing date, used publicly in China or known to the public in other ways, and no identical invention or utility model has been filed with the patent administration department of the State Council by others and recorded in the patent application documents published after the filing date. Includes three meanings:
1. The time limit for judging whether there is novelty is based on the filing date of the patent application. This is also the standard stipulated in the patent laws of most countries in the world. According to the relevant provisions of this law, the date when the patent administrative department of the State Council receives the patent application documents is the filing date. If the application documents are mailed, the postmark date sent shall be the application date. Where priority is enjoyed, it refers to the priority date. Inventions and utility models for which patents are applied are new technologies, that is, they are novel, as long as they are not available in the prior art or are not known to the public. Existing technology refers to the technical content that the public can know before the application date. The technical content in a confidential state is not known to the public, so it does not belong to the existing technology.
2. To judge whether it is novel, whether the invention or utility model for which the patent is applied has been made public and become known technology shall prevail. Where the same invention or utility model has not been publicly published in domestic and foreign publications, publicly used in China or known to the public in other ways before the filing date, it meets the requirements of novelty. The "same invention or utility model" mentioned here means that the technical fields and purposes are the same, the technical solutions are essentially the same, and the expected effects are the same. The "publicity" mentioned in this article includes: (1) publication publicity. Refers to the fact that the same invention has been recorded in official publications. The geographical scope of publication is the whole world, including both domestic and foreign countries. Before the filing date, as long as any publication in the world has published the same invention and creation, the invention and creation is not novel. Publications include all kinds of patent documents, magazines, books, academic papers, textbooks, technical manuals, etc., as well as all kinds of microfilms, films, photographic negatives, tapes, records, CDs, etc. made by means of electricity, light and photography. Publications are not limited by geographical location, language or acquisition method, nor by age. For some publications marked with the words "internal publications", if confidentiality is required within a specific scope, they are not public publications. (2) Use publicity,It refers to the disclosure of the technology to the public due to the application of this technology, such as the manufacture, sale, use, public display and performance of new products. The scope of public use is limited to China. (3) otherwise known to the public. This mainly refers to other public ways that can be known to the public. Including oral publicity, such as reports, seminars, radio or television broadcasts, etc., which can make the public know the technical content. The scope of this public way is also limited to China.
3. Whether the same invention or utility model has been filed by others and recorded in the patent document, which is customarily called "conflicting application". Since only one patent right can be granted for an invention-creation, if someone else has filed an application for the same invention or utility model with the patent administration department of the State Council before the filing date, and it is recorded in the patent application documents published after the filing date, that is, in case of conflicting application, in order to avoid repeated authorization of the same invention or utility model patent application, the invention or utility model applied for first is regarded as the existing technology of the invention or utility model applied for later, and the latter application is not novel.
Third, the third paragraph of this article stipulates the meaning of "creativity", that is, compared with the existing technology before the filing date, the invention has outstanding substantive characteristics and remarkable progress, and the utility model has substantive characteristics and progress. The "existing technology" mentioned here refers to the technology that was publicly published in domestic and foreign publications, publicly used in China or known to the public in other ways before the application date, that is, the existing technology.
1. To judge whether an invention for which a patent is applied meets the criteria of creativity is whether the invention has "outstanding substantive characteristics" and "remarkable progress". The "outstanding substantive features" mentioned here means that the invention has obvious essential differences compared with the prior art, which is not obvious to the ordinary technical personnel in the technical field to which the invention belongs. He cannot directly obtain all the necessary technical features of the invention from the prior art, nor can he obtain them through logical analysis, reasoning or experiment. If the invention can be obtained in the above way, the invention does not have outstanding substantive characteristics. The "remarkable progress" mentioned here means that from the technical effect of the invention, it has made great progress compared with the existing technology. Including: (1) the invention has solved the technical problems that people have been eager to solve, but they have never been successful; (2) The invention overcame the technical prejudice; (3) The invention has achieved unexpected technical effects; (4) The invention was a commercial success.
2. To judge whether a utility model for which a patent is applied meets the creative standards, the requirements are lower than those for invention patents, as long as the utility model has substantial characteristics and progress, and it is not required to be "prominent" or "remarkable".
Four, the fourth paragraph of this article defines the meaning of "practicality", which means that the invention or utility model can be manufactured or used, and can produce positive effects. Includes the following meanings:
1. It can be manufactured. As a technical scheme of invention or utility model, it should be achievable, that is, if the purpose of the invention is to manufacture a product, then the product must be manufactured according to the technical scheme of the invention.
2. be able to use it. As an invention or utility model, the technical scheme must be able to be implemented. If the invention is a technological method, it should be used in industrial production.
3. It can produce positive effects. Compared with the prior art, the economic, technical and social effects of the invention or utility model should be positive and beneficial. Inventions or utility models that are obviously useless, divorced from social needs, seriously pollute the environment, seriously waste energy or resources, and harm personal health are not practical.
4. It must be reproducible. As a technical scheme, the invention or utility model should be realized repeatedly. That is, technicians in the technical field can repeatedly implement the technical scheme adopted in the patent application to achieve its purpose according to the disclosed technical content. If it is a product, it should be able to be manufactured repeatedly; if it is a method, it should be able to be used repeatedly.

Article 23. The design for which the patent right is granted shall be different from or similar to the design that has been publicly published in domestic and foreign publications or publicly used in China before the filing date, and shall not conflict with the legal rights previously obtained by others.
[Interpretation] This article is about the requirements for granting a patent right to a design.
First, the design should be novel. That is, it is different from and not similar to the design that has been published in domestic and foreign publications or used publicly in China before the application date. The scope of its publication is domestic and foreign, and the scope of its public use is domestic. The "public use" mentioned here means that there is no identical physical object for public sale or use before the application date. Therefore, in terms of novelty, it is the same as the standard of invention and utility model.
Second, the design should be creative. That is, it is not the same as or similar to the existing design. "Different" here means different products and different designs. Different products mean that the uses and functions of products are not exactly the same. Different designs mean different shapes, patterns and colors. It should be pointed out that the same design, when used in different products, should not be considered as the same appearance design.
Three, shall not conflict with the legal rights obtained by others in advance. Here, "the legal rights obtained in advance" refers to the legal rights that others have obtained before the designer applies for a patent. This prior right mainly refers to: trademark right, copyright (mainly refers to art works), portrait right and so on. Because design refers to a new design that is aesthetically pleasing to the shape, pattern, color or their combination of products and is suitable for industrial application, it is easy to conflict with trademark rights, copyright and other rights. Therefore, legal provisions shall not conflict with these rights. That is, if someone else has obtained the above legal rights in advance, the applicant for a patent for design shall not obtain a patent right for the design of the product with these trademarks and works of art. This provision is a new addition to this revision of the Patent Law, with the purpose of avoiding conflicts of rights, causing disputes and harming the interests of those who have previously obtained legal rights.

Article 24 An invention-creation applying for a patent shall not lose its novelty in any of the following circumstances within six months before the date of filing:
(1) It was exhibited for the first time at an international exhibition sponsored or recognized by the China Municipal Government;
(2) It was first published at a specified academic or technical conference;
(three) others disclose the contents of the applicant without the consent of the applicant.
[Interpretation] This article is about the exception that the disclosure of inventions and creations does not lose novelty.
1. According to the provisions of Article 22 of this Law on the novelty of inventions and utility models, it is a basic principle that an invention for which a patent is applied will lose its novelty and cannot be patented if it has been made public before the date of application. But this basic principle is not absolute, and there are exceptions. The patent laws of many countries stipulate that the invention-creation can be disclosed without losing novelty within a certain period before the application date, that is, the so-called disclosure without losing novelty. This article is the patent law of our country’s disclosure of not losing novelty.
2. The time limit for publication without loss of novelty shall be within six months before the date of filing. This period is also called grace period, that is, within six months before the date of application, the application will not lose its novelty if the circumstances stipulated in this law occur. If you file a patent application after this time limit, it will no longer be novel and should not be granted a patent right.
Three, no loss of novelty, the provisions of this article are three:
1. It was exhibited for the first time at an international exhibition sponsored or recognized by the government of China. Including two meanings: First, it must be an international exhibition sponsored or recognized by the China government. International exhibitions hosted by the government of China include international exhibitions hosted by various departments in the State Council or the State Council or organized by other organs or local governments with the approval of the State Council. International exhibitions recognized by China government are those held at home and abroad, which are not held by China government, but are recognized by China government. Second, it must be an international exhibition, that is, besides the products of the host country, there should also be exhibits from foreign countries. Inventions and creations exhibited in international exhibitions that are not sponsored by the China government or recognized by the China government will no longer be novel.
2. It was first published at a specified academic conference or technical conference. The "academic conference or technical conference" mentioned here has certain restrictions and must be "prescribed" with a certain scale and specifications. According to the detailed rules for the implementation of the Patent Law, it refers to an academic conference or technical conference organized by the relevant competent authorities in the State Council or national academic organizations. It does not include academic conferences or technical conferences organized by ministries or commissions of the State Council or national societies. Inventions and creations published for the first time at academic conferences or technical conferences that meet the above requirements shall not lose their novelty.
3. Others disclose the contents without the consent of the applicant. That is, the disclosure of others against the applicant’s original intention. The ways for others to disclose the contents of their inventions and creations without the consent of the applicant may include: others disclose the contents of the applicant’s inventions and creations without complying with the express or implied confidentiality obligations; Others use threats, fraud, theft, espionage and other improper means to learn the content of the invention and creation from the inventor or any other person who has been told by him and then make it public. The disclosure of these two cases is against the applicant’s original intention and is illegal.

Article 25 No patent right shall be granted for the following items:
(1) scientific discoveries;
(2) Rules and methods of intellectual activities;
(3) Methods of diagnosis and treatment of diseases;
(4) Species of animals and plants;
(5) substances obtained by nuclear transformation.
A patent right may be granted to the production method of the products listed in Item (4) of the preceding paragraph in accordance with the provisions of this Law.
[Interpretation] This article is about the provisions on the results of intellectual activities that do not grant patent rights.
First, the purpose of establishing a patent system is to protect the achievements of intellectual activities within the legal scope. Inventions and creations that are novel, creative and practical, and meet other conditions stipulated in the patent law, belong to intellectual achievements protected by patents, and can be patented according to law. At the same time, according to the provisions of this article, the achievements of the following kinds of intellectual activities do not belong to the scope of patent protection and no patent right shall be granted:
1. Scientific discovery. It refers to the discovery and understanding of unknown substances, phenomena, changing processes, their characteristics and laws that have objectively existed in nature. These inventions and understandings are not a technical solution in themselves, not inventions in the sense of patent law, and cannot be directly implemented to solve specific technical problems in a certain field, so they cannot be granted patent rights.
2. Rules and methods of intellectual activities. It refers to people’s thinking movement, which is an abstract thing and a means or process for people’s brain to carry out spiritual and intelligent activities. It only guides people to think, judge and remember the information they express, and it does not need to adopt technical means or abide by the laws of nature, and it does not have technical characteristics, so it cannot be granted a patent right. For example, traffic rules, dictionary arrangement methods, information retrieval methods, speed algorithms or formulas, rules and methods of various games and entertainment, and competition rules cannot be patented.
3. Diagnosis and treatment of diseases. It refers to the direct implementation of living human beings or animals for the purpose of treating diseases, which cannot be monopolized by a few people because it involves human health. The "diagnosis method of disease" mentioned here refers to the whole process of identifying, studying and determining the cause or focus state of living human or animal. The "treatment of diseases" mentioned here refers to the process of blocking, alleviating or eliminating the cause or focus in order to restore or obtain health for living human beings or animals. This kind of treatment or diagnosis method cannot be manufactured or used in industry, and it is not practical, so it cannot be patented. For example, ultrasonic diagnosis, acupuncture, anesthesia, massage and other treatment methods, surgical methods and so on. The TRIPS agreement also stipulates that members can exclude diagnostic methods, therapeutic methods and surgical methods for treating humans or animals from patentability.
4. Animal and plant varieties. Animal and plant varieties refer to new varieties of animals and plants cultivated by biological methods. Animals and plants are living objects, naturally generated, products of nature, not created by people, and cannot be produced by industrial methods, so they do not have creativity and usability in the sense of patent law, so they cannot be granted patent rights. However, animal and plant varieties can be protected by laws other than the patent law. In this regard, the TRIPS agreement stipulates that members should protect new plant varieties by patent system or effective special system, or by any combination system. For the protection of new plant varieties, many countries in the world have also formulated corresponding laws and regulations. In 1997, the State Council promulgated the Regulations on the Protection of New Plant Varieties in People’s Republic of China (PRC), which stipulated the definition of new plant varieties, the content and ownership of variety rights, and protected new plant varieties that met the regulations.
5. Substances obtained by nuclear transformation. Mainly refers to the use of accelerators, reactors and other nuclear reaction devices, through nuclear fission, nuclear fusion and other methods to obtain elements or compounds. Because the substances obtained by nuclear transformation are related to the great interests of the country’s economy, national defense, scientific research and public life, and are related to national security, it is not suitable for publicity, and most countries do not grant patents to such substances.
2. Patents may be granted for the production methods of animal and plant varieties in accordance with the provisions of this Law. The "production method" mentioned here refers to non-biological methods, excluding mainly biological methods for producing animals and plants. This kind of method can be granted a patent right because of the intervention of technical elements and the main control or decisive role in the ultimate goal or effect. Patents can be obtained for microorganisms and microbial methods.
        

CCTV News:On July 25th, the Information Office of Nanjing Municipal People’s Government held the fifth news conference on the prevention and control of COVID-19 epidemic in Nanjing.

Yang Dasuo, deputy director of Nanjing Health and Health Commission, introduced the latest situation of epidemic prevention and control in Nanjing:

First, the new cases. July 24, 2021 0— — At 24: 00, there were 2 new confirmed cases (all common types) in COVID-19 and 2 new asymptomatic infected cases. Among these 4 cases, Jiangning, Lishui, Jianye and Gaochun each had one case. Up to now, there are 37 confirmed cases in Nanjing (including 14 mild cases and 23 common cases), and there are 20 asymptomatic infections in Nanjing. The relevant information and trajectories of newly confirmed cases and asymptomatic infected persons have been published through WeChat WeChat official account and Weibo such as "Nanjing Publishing" and "Healthy Nanjing".

Second, the medical treatment work. Up to now, 37 confirmed cases have been treated in Tangshan Hospital of Nanjing Second Hospital (Nanjing Public Health Medical Center), and their vital signs are stable. At present, 20 asymptomatic infected people are also in centralized isolation and medical management in Tangshan Campus of Nanjing Second Hospital.

III. Delineation of risk levels. According to the national and provincial requirements for accurate prevention and control of COVID-19 epidemic, the epidemic risk level in some areas of Nanjing has been adjusted since July 25, 2021. Since July 25, 2021, the building area where Wutai Building Materials Store is located at the intersection of provincial road 239 and Yaoding Road in Gaochun District of Nanjing has been adjusted from a low-risk area to a medium-risk area. The risk levels in other regions remain unchanged. From July 25th, 2021, No.26 Suojie, Nanyuan Street, jianye district was changed from a low-risk area to a medium-risk area. The risk levels in other regions remain unchanged. From July 25th, 2021, No.388 Xinling Road, Maoting Community, Lukou Street (medium risk), Shinian Village, Lukou Street (adjusted from medium risk to high risk). The risk levels in other regions remain unchanged. Since July 25, 2021, Xiangzhangyuan in Vanke City, Yongyang Street, Lishui District has been adjusted from a low-risk area to a medium-risk area. The risk levels in other regions remain unchanged.

Close contacts and sub-close contacts with positive people on the same flight must be centralized isolated.

Explanation: that is, if there is a case of positive infection or close contact and sub-close contact of positive infection on a plane, all the people on the same plane should be isolated.

On or after July 10, if there is a history of airport travel in and out of Hong Kong and a record of ticket purchase, standardized home isolation shall be implemented. Do not have the conditions of home isolation, should be centralized isolation.

Explanation: home isolation observation means that it is best to live alone; If conditions do not allow the choice, a well-ventilated room in a house should remain relatively independent as an isolation room, and it is best not to use air conditioning in the room, especially the central air conditioning shared with other rooms; If conditions permit, try to use a separate bathroom and avoid sharing it with other family members. This is home medical observation.

Those who stay at the airport for more than half an hour and enter the lobby but have not touched the public facilities inside the airport should be tested for nucleic acid three times a week according to the specifications. These three times of nucleic acid testing are also required, not three times in a row, but the interval between two times should exceed 24 hours, and three times of nucleic acid testing have been done in various ways, such as mixed sampling at 1: 5 or 1: 10, and the time interval can meet the requirements without re-testing. What about those who have been in contact with the airport? If you have touched it, you should observe it at home.

If you stop at the airport for a short time, within half an hour, and you don’t enter the airport lobby, such as giving someone away or passing by, you can turn it into a green code if the nucleic acid test is negative.

Those who pass through the airport by means of transportation and have never been to the airport can turn green after passing the big data screening. Because in high-risk areas, the degree of risk is still relatively large, and there are still risks, so everyone should be responsible for themselves and the society, and be realistic about their own situation.

As for how to decode these policies, the Nanjing area "Su Kang codeThe transcoding policy is based on the documents issued this time. You can learn how to do the specific transcoding through the 12345 government hotline, and there will be a corresponding team to do this, so as to provide you with a more convenient and convenient process.

Yesterday, the Center for Disease Control and Prevention in jianye district reported that a citizen’s initial screening result of nucleic acid test was positive (this citizen was engaged in ground work at Lukou Airport, and now he was diagnosed as an ordinary case and was treated in isolation in a designated hospital in Nanjing). jianye district immediately launched an emergency plan and took the following measures:

The first is to carry out flow adjustment and control personnel classification. As of 0: 00 today, through the flow adjustment, there are 44 close-contact and sub-close-contact personnel in jianye district, who have been transported in strict accordance with the protection regulations and concentrated on medical observation. All the secret and sub-secret personnel outside the area shall be notified to the local area for isolation management. There are 17 people in 8 households in the same unit of this person’s residence, and all of them are centralized and isolated according to the close contact personnel.

The second is to implement closed management of the community, and other people in the community conduct home health monitoring.

The third is to carry out nucleic acid sampling and testing. By the end of 0: 00, 1178 people were sampled from the close contact personnel, the sub-close contact personnel and the people in the residential area, and 46 samples were sampled from the environment such as the residence, corridor and elevator of this case. All the test results were negative.

The fourth is to carry out environmental disinfection. The residence, building and unit of the case were disinfected.

The fifth is to classify and deal with community garbage. The garbage generated by the case family and the protective articles used by the staff involved in closed management are treated as medical wastes; Other garbage generated by residents in the community will be collected and treated separately by special personnel every day.

The second representative group interview was held, and five grassroots representatives spoke for the people.

Text/Jinyang. com reporter Luo Shi

Figure/Jinyang. com reporter Tang Mingming

Yesterday morning, a meeting of the 13th National People’s Congress of Guangdong Province held the second collective interview for delegates. Five representatives from the provincial people’s congress at the grassroots level actively spoke for the people on livelihood topics such as medical care, pension, talents, pollution control and beautiful countryside construction.

Wang Maosheng, deputy of the Provincial People’s Congress and president of Gaozhou People’s Hospital:

Building a "Strong Health Province" and Paying Attention to "Strong Grassroots"

Realize the goal of "serious illness does not leave the big county"

The work report of the provincial government puts forward "promoting the construction of a healthy Guangdong". In this regard, Wang Maosheng said that Guangdong should pay attention to "strong grassroots" in the process of building a "strong health province".

Wang Maosheng said that the Guangdong Provincial Health and Family Planning Commission and the Medical Reform Office have set two development models for primary health care: one is the urban model. Through community centers and family doctors, Shenzhen Luohu Hospital Group has achieved home visits by family doctors for minor illnesses, community solutions for common diseases, and treatment for serious illnesses in large hospitals. "There is no shortage of talent echelon in cities and sufficient funds, so the problem is not very big."

The other is Gaozhou mode. Wang Maosheng said, "County hospitals can’t recruit people because of lack of talents, lack of technology, insufficient funds, and inadequate management. If they are recruited, they can’t stay." More than a decade ago, Maoming Gaozhou two-level government simplified administration and decentralized power, and "borrowed" talents from Beishangguang to Gaozhou for surgery, building a specialist and building a platform. "Talents may not be’ owned by me’, but they can be used by me."

At the same time, he proposed that the goal of "serious illness does not leave a big county" should be achieved. "It means that there is a strong central hospital on the basis of the county. If there is such a hospital in eastern Guangdong, western Guangdong and northern Guangdong, then the people don’t have to work so hard."

Lu Cuifen, deputy to the Provincial People’s Congress and deputy secretary of the Party Committee of Wenchong Stock Economic Union in Huangpu District, Guangzhou:

Make-up of living security for urban and rural subsistence allowances

"Proportion" cannot be used as a means of increase.

According to the work report of the provincial government, in 2018, the minimum standard of basic old-age pension for urban and rural residents in the province will be raised from the original 120 yuan to 138 yuan, an increase of 15%.

In this regard, Lu Cuifen said that due to the original low base, "15% growth" can not solve the problem of old-age care for ordinary people in eastern and western Guangdong. She suggested that in future adjustments, the basic pension for urban and rural residents can be greatly increased to solve the problem of low pensions in eastern and western Guangdong.

She also pays attention to the gap between urban and rural subsistence allowances. "In 2018, the per capita subsistence allowance for urban and rural subsistence allowances in Guangdong Province will increase from 457 yuan and 206 yuan per month to 503 yuan and 228 yuan respectively. Both increase by about 10%. I don’t think’ proportion’ can be used as a means of increase in the future, otherwise the gap between urban and rural areas will widen. "

In addition, she suggested further strengthening the construction of national fitness sports venues. "On the one hand, we should do a good job in the construction of sports venues. At the same time, it is necessary to increase the intensity of opening up concessions so that the broad masses can share good sports facilities and enhance the people’s sense of acquisition, happiness and security. "

Peng Zijian, deputy of the Provincial People’s Congress and executive director of Guangdong Lingfeng Group Co., Ltd.:

It is suggested that the provincial finance set up a medical development fund.

Let high-end talents "change from blood transfusion to hematopoiesis"

"In the provincial government work report, many economic indicators in Guangdong Province ranked first in the country. But we must also clearly realize that the gap between Guangdong, East and West and the Pearl River Delta is very huge. " Peng Zijian said that this gap is not only reflected in economic development, but also in public services and talent gathering.

How to attract and retain talents? Peng Zijian said that the most scarce talents in the eastern and western regions of Guangdong are concentrated in the fields of education and medical care. "I suggest integrating resources and rational layout throughout the province and establishing multiple regional medical centers in the eastern and western regions of Guangdong; At the same time, we can also refer to MSF’s short-term support to backward countries to formulate relevant policies or regulations, so that some doctors with intermediate titles can serve in primary medical units for six months to two years. While solving the needs of patients, they can train local doctors and improve local medical standards. "

At the same time, he stressed that it is suggested that the provincial finance should arrange medical development funds, focus on building a platform to solve the problem of talent retention. "We should change the past strategy of attracting talents only by income, and attract talents more by platform, so that high-end talents can stay, develop and become talents, and’ change from blood transfusion to hematopoiesis’.

Liu Xiaole, deputy of the Provincial People’s Congress and member of Yangjiang Reservoir Resettlement Leading Group Office:

Strengthening responsibility assessment in the process of promoting river length system

Using incentive mechanism to support cities with good results

"The river length system plays an important role in water pollution control in Guangdong. How do you think the government should further promote water pollution control?" Regarding this question raised by the reporter, Liu Xiaole said that Guangdong should give full play to the role of grass-roots river chiefs in the process of water control and strengthen the responsibility assessment of river chiefs.

"As far as the current situation is concerned, there is still a relatively common problem for grass-roots river chiefs, that is, their understanding of the river length system needs to be improved, and there are still some situations in which the implementation of responsibilities is not in place." Liu Xiaole suggested that in the next step, Guangdong should continue to increase the training of grass-roots river chiefs, increase publicity on water control, and form a good atmosphere for water control.

At the same time, in the process of promoting the river length system, it is necessary to strengthen the responsibility assessment and make full use of the reward and incentive mechanism. "We should give full support to some cities and cities that have promoted better and implemented better; For advanced individuals with good grades and outstanding work, they should be fully affirmed and praised to drive everyone’s enthusiasm for work. "

In addition, she suggested that efforts should be made to protect high-quality water sources. "We should not only treat the inferior but also protect the superior. To develop in protection, we must never take the old road of’ pollution first and then treatment’."

Pan Limei, deputy of the Provincial People’s Congress and director of the R&D Center of Shaoguan Yalu Environmental Protection Industry Co., Ltd.:

Hope to strengthen rural environmental protection

Comprehensively promote the construction of beautiful countryside.

"At this provincial people’s congress, I am more concerned about the problem that it is difficult to introduce and retain professional and technical talents in eastern and western Guangdong." Pan Limei said that the shortage of talents has become a bottleneck in the development of eastern and western Guangdong (especially in the mountainous areas of northern Guangdong). "I hope that the government can provide policy support to professionals working in eastern and western Guangdong, help them to introduce and retain professional and technical talents, and promote the solution to the problem of insufficient and unbalanced development."

As a scientific and technological worker engaged in the research and development of environmental protection technology, Pan Limei also pays special attention to the problem of rural environmental pollution control. "With the development of economy, the problem of agricultural environmental pollution in rural areas has become increasingly prominent, and I hope the government can strengthen environmental protection in rural areas and promote the construction of beautiful countryside in an all-round way."

　　Needle puncture, blood drawing, ozone injection, etc., and then the blood is returned to the body … … Recently, a medical beauty project named "Blood Purification" became popular on social media because of many "Amway" in online celebrity. In online celebrity’s sharing posts, it is frequently mentioned that "blood purification" can resist aging, promote metabolism, regulate immunity and help the body to detoxify. Some merchants even claim that it can treat tumors. But is this really the case?

　　A survey by Beijing Youth Daily reporter found that this project, known as "Beauty Black Technology", has been carried out in medical and beauty institutions and private hospitals in Beijing, Guangdong and Nanjing, with a single charge ranging from 3,000 yuan to 50,000 yuan. According to the description of beauty institutions and private hospitals, "blood purification" is simple, safe and reliable. In this regard, medical experts reminded that the "blood purification" project is not suitable for everyone, not a beauty care project, but an operation. Patients in need should follow the doctor’s advice and receive treatment in regular hospitals. "If you operate in an environment that is not up to standard, there will be risks such as blood infection."

　　In addition, the health departments in Beijing, Guangdong and Nanjing all said that they had not approved the relevant qualifications of the beauty institutions and private hospitals involved in this area to carry out such "blood purification" medical beauty projects, and suggested that consumers should report the relevant situation to the health department in time.

　　raise concerns

　　Medical beauty project "blood purification" became popular.

　　Recently, a "blood purification" project has quickly become popular in the medical and beauty circles, and many online celebrity and beauty bloggers have fancy "Amway" on social platforms. Online celebrity mentioned that she experienced the project in Japan by a friend’s recommendation. The steps were simple: pricking a needle, drawing 100 ml of blood, and then injecting ozone. During this time, online celebrity said that he saw his blood "change from dark red to bright red". Finally, the "purified" blood is returned to the body. Online celebrity said that after "blood purification", "I only slept for five hours every day but I was not sleepy at all". The post also showed photos of her "doing projects".

　　The reporter of Beiqing Daily noticed that there are not a few "Amway posts" about "blood purification" on social platforms. A beauty blogger told the reporter of Beiqing Daily that he had done the project in Ginza, Tokyo. "I have done it three times, and it is not easy to get tired after I finish it." In addition to Japan, South Korea and Thailand, many netizens "Amway" medical and beauty institutions in Guangzhou, Nanjing and even Beijing.

　　Despite being sought after by many beauty lovers, netizens have mixed opinions. Some netizens bluntly said that this is paying an "IQ tax"; There are also medical experts who question that once there are irregularities in the operation process, it is very likely to cause injury or even death.

　　Journalist investigation

　　Be touted as an "anti-aging artifact"

　　An unannounced visit by the reporter of Beiqing Daily found that there are not a few beauty and plastic surgery institutions in China that claim to be able to carry out "blood purification" projects. There are two specific forms: one is the direct operation of the plastic surgery hospital; The other is the beauty salon "matchmaking", which leads the passenger flow to private hospitals, which are charged by the beauty salon, but operated by private hospitals.

　　A staff member of a beauty agency named "Qinxin Yimei" located in Fogang County, Qingyuan City, Guangdong Province said that they are doing a "blood purification therapy" introduced from Germany. "Take out your own blood, then mix and purify the high-concentration and high-dose active oxygen with the blood, and then return your own blood to the body." The staff member said, "Many online celebrity and celebrities in China are doing it here, and they can excrete a lot of toxins from the body." Subsequently, the staff sent a number of videos and photos of customers "doing projects".

　　Asked about the charge, the staff sent a leaflet page, which read "1000 ml of net blood is worth 79800 yuan at a time". However, she said that it is more recommended for reporters to "do cards", saying that the more recharge, the lower the single charge price. "After the discount, the single charge ranges from 10,000 yuan to 50,000 yuan."

　　Coincidentally, when the reporter of Beiqing Daily consulted the anti-aging problem as a consumer, the staff of "Nanjing Mijia DR.CICI Plastic Surgery Hospital" recommended a similar "blood purification" project to the reporter of Beiqing Daily. In the video sent by the other party, a woman in a nurse’s uniform kept shaking with a bottle filled with blood, and a patient waiting for "blood transfusion" was lying next to the woman.

　　Seeing the reporter’s interest, the staff further introduced that the agency’s "blood purification" project is divided into two types: large circulation and small circulation. "The price of large circulation is 50,000 yuan, and the price of small circulation is 3,980 yuan. Great circulation is the whole body blood circulation. Blood is drawn from one arm, purified by the machine, and then returned to the body from the other arm. The small circulation is to pump 100ml of blood, then inject ozone into the blood with a machine, and then return the blood to the body. "

　　Beijing luodian

　　Clients are drained to private hospitals.

　　"Great Cycle" and "Small Cycle" have a new expression in a beauty salon named "Kiss of Flowers" in Chaoyang District, Beijing — — "adsorption column" The staff introduced, "‘ Adsorption column ’ Is added in ‘ Blood purification ’ A link in the process will absorb impurities and precipitates in the blood, which will double the efficacy, but the price is relatively high after addition. " Different from the first two cosmetic and plastic surgery hospitals, the staff of "Kiss of Flowers" said that they did not operate the "blood purification" project, and after signing an agreement with customers, they would take customers to a private hospital named "Ciming ‘ao Sub-health Management Hospital" for specific operations.

　　Subsequently, the reporter of Beiqing Daily consulted Ciming ‘ao Sub-health Management Hospital in beiyuan road, Chaoyang District as a citizen. A "health consultant" of the hospital introduced that "blood purification" is a medical beauty project with "anti-aging effect" in the hospital, and admitted that it has "channel cooperation relationship" with many beauty salons.

　　As for the benefits of "blood purification", the above-mentioned staff sent a paragraph saying that the project can "reduce hyperlipidemia and high cholesterol; Eliminate environmental toxins and metals in the body to prevent the occurrence of cancer; Remove endotoxin from the liver and improve the detoxification function of the liver; Treatment and prevention of complications of diabetes; Repair damaged myocardium and blood vessel wall to prevent cardiovascular and cerebrovascular diseases; Improve male impotence symptoms and sexual function, improve immunity; Improve cell activity, rejuvenate the vitality of the body, and effectively prevent premature aging; Improve the symptoms of numbness and fear of cold in hands and feet, make qi and blood smooth, and improve the gloss and whiteness of skin. "

　　No photo receipt, only "medical examination fee"

　　"We are a regular hospital, and physical examination is our main project. If you are not at ease, you can come and have a look in person. " Aware of the reporter’s concerns, the staff of Ciming ‘ao Sub-health Management Hospital took the initiative to make suggestions.

　　Yesterday morning, a reporter from Beiqing Daily and his party came to this hospital in beiyuan road, Chaoyang District. According to the salesperson, "blood purification" is carried out in the "sub-health conditioning center" inside the hospital. "Customers are all members of the hospital, and there are customers brought by the channel, so there is no need to publicize them."

　　Then, two salespeople took the reporter of Beiqing Daily to a consulting room on the second floor of the physical examination center. A "director" wearing a white coat sat down and began to introduce the benefits of "blood purification" in anti-aging to reporters. Subsequently, the salesperson introduced the price of "blood purification". "Yes ‘ Adsorption column ‘ The big cycle is 50 thousand yuan at a time. The small cycle of pumping out a small amount of blood and injecting ozone is not done alone, but combined with the large cycle. The price is 10 times for a course of treatment, totaling 50,000 yuan. " After the reporter of Beiqing Daily asked "whether it is possible to invoice", the salesperson said, "This is our internal price, and we can’t invoice. Even if it is a receipt, we can only write the medical examination fee."

　　During the consultation, in addition to a director, there are two salespeople, a man and a woman, who always follow the reporters of Beiqing Daily, and are not allowed to take photos casually.

　　Subsequently, the reporter of Beiqing Daily asked if it was possible to "look at the departments doing the project", and the staff replied, "It’s a sterile room, and everyone is doing it in it ‘ Blood purification ’ It is not convenient to see. " After repeated requests, two salespeople led the reporter of Beiqing Daily to visit the general ward, and said, "The ward for blood purification is similar to the general ward, but the bed will be better than this." The reporter of Beiqing Daily saw that the bed in the general ward of the hospital is similar to a single or double bed in a hotel. The staff added, "When doing the project, the hospital ward bed is used, and an instrument for blood purification will be placed next to it."

　　Regarding the treatment risk, the sales staff insisted that it was "absolutely safe" and stressed that they had relevant qualifications approved by the health department. A salesperson said, "This is equivalent to the process of blood collection. This arm is drawn out, and after the circulation of the machine, the left arm enters and exits the right arm, and the (filtered) fresh blood is injected back from the other arm. After you finish, you can see a small tube filled with impurities extracted from your blood. "

　　Expert opinion

　　If the environment is not up to standard, there will be the risk of infection.

　　For the "blood purification" medical beauty project launched by beauty institutions and private hospitals, Dr. Wang, an attending doctor in the rehabilitation department of a 3A hospital in Beijing, told the reporter of Beiqing Daily, "What they said ‘ Blood purification ’ The project should be an auxiliary medical project carried out in regular hospitals, which is mainly suitable for the auxiliary treatment of patients with physical pain, herpes zoster, cardiovascular and cerebrovascular diseases, but not for everyone. ‘ Anti-aging ’ The beauty project. Moreover, this is an operation, and even if it is carried out in a sterile operating room of a regular hospital, there will be a certain risk of infection. "

　　Zhu Chenggang, deputy director of the Cardiovascular Department of Fuwai Hospital, said that the blood purification project recommended by some beauty salons and medical institutions costs tens of thousands of dollars, and the curative effect is fantastic, claiming that it can beauty beauty, and even has a miraculous effect on treating tumors, which should be regarded as selling fear and over-publicizing. Zhu Chenggang pointed out that if you want to reduce blood fat and treat cardiovascular diseases, you must go through regular hospitals and use professional machines to achieve blood purification. There is no need for ordinary patients to carry out such treatment. Only patients with a family genetic history or a particularly high blood fat content can apply to such treatment methods.

　　Text/reporter Zhang Ya Wang Tianqi Wang Haoxiong

　　Intern Zhang Yaolin Jing Wang

　　Coordinator/Jiang Shuo

　　Official response

　　Many health departments said that the project had not been approved.

　　The reporter of Beiqing Daily consulted the health departments in Fogang County of Qingyuan City, jianye district of Nanjing City and Chaoyang District of Beijing where the three medical institutions are located.

　　On February 21st, the staff of the Medical Administration Department of Fogang County Health Bureau in Qingyuan City, Guangdong Province said that the approved practice scope of the beauty hospital involved was cosmetic surgery, cosmetic dermatology and medical laboratory. "It is ok to do it within the skin, which is similar to hemodialysis ‘ Change blood ’ This kind, they don’t have this permission. " The staff said that they do not know the specific situation of this "treatment" in the beauty hospital involved for the time being, and will conduct an investigation according to the complaints of consumers.

　　On February 22nd, the reporter of Beiqing Daily called the Nanjing jianye district Health Bureau, and the staff said that the "blood purification" project described by the plastic surgery hospital involved had not been filed in the unit. "Blood things are no joke, even when many large hospitals are carried out, cases of infection can’t be avoided. We will ask the staff to investigate the specific situation of their project. "

　　On February 22, the reporter of Beiqing Daily called the Medical Administration Department of Chaoyang District Health Bureau as a citizen to ask whether the hospital involved had the relevant qualifications for "blood purification". The staff said that Ciming Aoya Hospital is a private hospital with a medical institution practice license. "If the hospital has a medical beauty department, it can carry out medical beauty services." After listening to the description of the "blood purification" project, the staff clearly stated, "I have never heard of this project you mentioned. You ask him to take out the approval and qualification materials and see what we give him for approval. It’s definitely not this. We have not approved this (blood purification) project here. " The staff suggested that patients who are unwell should go to public hospitals for treatment.

　　The reporter of Beiqing Daily noticed that as early as 2005, the Ministry of Health had issued "Strengthening ‘ Blood therapy ’ Notice of management ". According to the circular, medical institutions in some parts of China carry out so-called "blood therapy" by collecting patients’ blood, carrying out treatments such as magnetic supplement, adsorption, oxygenation, radio frequency, purification and medicine addition, or directly processing blood in patients’ blood vessels by physical methods. The safety and effectiveness of most of these therapies lack scientific research and evidence-based medical evidence, and may cause harm to human body. In this regard, the Ministry of Health proposed that "blood therapy" which has been proved to be safe and effective in clinical application through basic research and clinical research evaluation at home and abroad can be standardized on the premise of clear indications. For example, "ultraviolet irradiation and oxygenation autotransfusion therapy" can be used for clinical treatment of bacterial, fungal and viral infections, low immune function, poisoning and so on. The controversial "blood therapy" should not be provided to patients as a clinical service item. For "blood therapy" which has neither basic research conclusion nor clinical research,All clinical applications will be stopped.

Hu Guohua data map

　Cctv news On March 29, 1984, a young man came to the office of the State Patent Office, which was still painting and laying bricks. He held the card "Patent applicants line up here, the first aerospace institute 207" in his hand, and held it up and hung it on the door frame. When the scattered people around him saw that the young man was the vanguard, they consciously began to line up. This young man is Hu Guohua.

It turned out that in 1984, China’s first patent law was officially promulgated and implemented in April. After learning this news, Hu Guohua, who was working in No.207 Institute of the Second Hospital of the Ministry of Aeronautics and Astronautics at that time, came up with the idea of fighting for the first invention patent and letting the national No.1 patent "blossom" in space. In order to ensure that astronauts can obtain the first patent, Hu Guohua came to the National Patent Office to inquire in advance. He found the office that accepts patent applications. Although he hasn’t officially started to apply, there are already many people around him who are wandering around like him. Hu Guohua had a brainwave and wrote a card "Patent applicants line up here, ranking first in Aerospace Institute 207". People who didn’t know what to do originally were lined up by Hu Guohua.

In the afternoon, Hu Guohua brought bedding and waited outside the office for three days and nights. On April 1, 1984, he was finally the first to submit the patent application. In December 1985, Hu Guohua successfully obtained the certificate with the patent number of "85100001.0" issued by the State Patent Office, and became the "No.1 Patent" inventor of New China. The patent he applied for is called "Variable Optical Filtering Real-time False Color Display Method and Device". Simply put, it is to turn a black-and-white picture of the earth taken from a satellite into a color image according to certain characteristics, so as to see more information.

Do not forget your initiative mind is only because of the space dream.

In 1966, 23-year-old Hu Guohua graduated from the Physics Department of Fudan University and was assigned to work in Beijing Institute of Physics, China Academy of Sciences. In 1970, he took the original research topic and transferred to the 207 Research Institute of the Second Hospital of the Seventh Machinery Department (later the Space Department) to engage in optical research. Since then, the space dream has been deeply rooted in Hu Guohua’s heart and has become the driving force for him to persist in developing products for so many years.

His laser group is the earliest unit to carry out modern physical optics research in China. It started not too late, but because of the new principle, high requirements and low output of scientific research equipment, it needs to spend a lot of foreign exchange to import from abroad. Hu Guohua was very upset when he saw this situation, so he decided to design a set of cheap, universal and systematic modern optical experimental device.

The road to design is full of hardships. The difficulties he encountered were enormous: there was no assistant, no funds, no factory building, and even no laboratory where a newly-developed experimental instrument was placed. Hu Guohua’s difficulties attracted Deng Xiaoping’s attention. With the support of important responsible comrades of the Institute, the Institute, the Ministry and the Central Committee, Hu Guohua’s belief was strengthened, and he worked day and night to develop and tackle key problems.

Once he tried to design a "resettable device" with a reset error of less than one thousandth of a millimeter. He thought about walking and eating, but turned a blind eye to people. One night, he designed another device. Because he used his brain too much, his eyes suddenly turned black and he couldn’t see anything until noon the next day.

In 1980, Hu Guohua also developed the "Holography and Optical Information Processing Experimental System", which consists of 15 sets of more than 60 devices, including lasers, shock-proof platforms, optical and mechanical components. It can do dozens of modern optical experiments, such as holography, laser speckle, image spectrum analysis, spatial filtering and optical information processing, and is widely used. It can make blurred electron microscope images or satellite photos clear, and promote the early realization of optical computers with faster speed and larger capacity than electronic computers. The successful trial production of this experimental system has filled a gap in optical research equipment in China. At that time, only a few countries such as the United States could make and use it.

70-year-old retired to "plant the sun"

As an astronaut, Hu Guohua always has an "aerospace dream" in his heart. He dedicated his best years to the aerospace industry. After retirement, Hu Guohua still insisted on his own aerospace dream and never stopped after his seventies.

In recent years, based on years of research in the field of optics, and considering the future of industrial development, the leaders of 207 research institutes decided to participate in the project competition of developing a large-scale solar simulator in a research institute in Beijing, and formed a research team with optical experts to manufacture a solar simulator with a diameter of two meters. Hu Guohua, who was retired at that time, was one of them.

After studying the information about the manufacture of solar simulators at home and abroad, Hu Guohua began to challenge the research and manufacture of solar simulators according to the requirements of Institute 207. He worked tirelessly. In order to buy the parts for manufacturing the solar simulator, he personally drove around Beijing and found the relevant manufacturers to customize it himself. For a component, he has been to an optical production factory in Tongzhou District, Beijing for many times. Because of the special components he requires, even the technicians who process the components don’t know much about it. Therefore, he became a teacher again, explaining the principles and requirements of manufacturing optical components to technicians.

At that time, Hu Guohua was over seventy years old, and everyone in the team affectionately called him "the elder". Hu Guohua said: "I have never felt that I am a ‘ Elder ’ It’s never too old to learn. " He taught his experience and knowledge to young people without reservation, and at the same time learned from them their enterprising spirit.

Stick to the same as before, the space is boundless

Professional innovation, in life, Hu Guohua is using the knowledge to serve the public.

After retirement, Hu Guohua once created a space haunted house for an old Beijing street in the New Dong ‘an market in Beijing. Through the combination of space sound equipment and sound and photoelectricity, the horrible scene is reproduced. At that time, tourists lined up to experience the sci-fi effect of space sound; Hu Guohua also applied optical knowledge to anti-counterfeiting technology, made anti-counterfeiting trademarks for Xinjiang Tobacco Company, and made contributions to cracking down on counterfeit and shoddy products and raising national tax revenue.

Hu Guohua often uses it to help some poor countries. In April 2016, some scientists and technicians from Malaysia and Indonesia planned to build hydropower stations in some mountainous areas of East Malaysia to solve the lighting and living problems for local people. At this time, they found Hu Guohua, and Hu Guohua immediately planned for them and led them to visit Jinhua, Zhejiang. He brought China’s technology to Southeast Asia, which not only enabled the residents in those areas to use electricity, but also enabled China to transfer technology and gained economic benefits.

But doing all this, Hu Guohua didn’t make a penny. He spends his energy and wisdom to help others, which fully shows the feelings of an astronaut, that is, he is open-minded and generous, and he is willing to do whatever he can, regardless of gains and losses.

For half a century, Hu Guohua’s determination and belief in practicing his space dream need not be repeatedly emphasized. He has been telling people that he is an astronaut and practicing his space dream with practical actions. (Text/Contributed by 207 Institute of Wang Ruoyu Aerospace Science and Technology Second Hospital)

Twenty-three departments jointly issued nineteen measures.
Accelerate the release of demand and expand residents’ consumption

With the consent of the State Council, 23 departments, including the National Development and Reform Commission, the Publicity Department of the Communist Party of China and the Ministry of Finance, jointly issued the Implementation Opinions on Promoting Consumption Expansion, Upgrading and Accelerating the Formation of a Strong Domestic Market (hereinafter referred to as the Opinions). The Opinions put forward 19 measures to promote consumption expansion and quality improvement from six aspects: market supply, consumption upgrading, consumption network, consumption ecology, consumption capacity and consumption environment, and help form a strong domestic market.

Expanding consumption is an important focus to hedge the impact of the epidemic.

The COVID-19 epidemic has had an impact on China’s consumption at present and even in the future, especially in the fields of shopping, catering, tourism, culture, education and entertainment.

"Releasing the suppressed and frozen consumer demand, cultivating and growing the new consumption and upgraded consumption that were born in the prevention and control of the epidemic, and making the physical consumption and service consumption be replenished, is one of the important points to hedge the impact of the epidemic." Chang Tiewei, deputy director of the Employment Income Distribution and Consumption Department of the National Development and Reform Commission, said that it is of great significance to promote consumption expansion and quality improvement while doing a good job in epidemic prevention and control.

Since last year, the CPC Central Committee and the State Council have deployed a series of policies to promote consumption, and various localities have successively introduced a number of targeted measures, such as Beijing, Tianjin, Shanghai and other places to build a new platform for consumption upgrading by cultivating night economy.

"The Opinions are the inheritance and development of previous policies." Chang Tiewei said that it not only inherited the previous policy orientations such as updating consumption and cultural tourism consumption, but also integrated into the new models, new formats and new industries in the current new consumption development.

To expand consumption, the key is to conform to the upgrading trend of residents’ consumption, break through the "blocking point" and "pain point" in the consumption field, break down the institutional and institutional obstacles that restrict consumption, and improve the governance capacity in the consumption field. The "Opinions" adhere to the structural reform of the supply side as the main line, seize the most potential consumption areas and focus on improving supply, constantly improve consumption policies, optimize the consumption environment, and stabilize consumption expectations.

Chang Tiewei introduced that the Opinions pay more attention to service consumption in terms of consumption types; Highlight holiday and night consumption in terms of consumption time; Accelerate the cultivation of new models such as online and offline integration in terms of consumption patterns; Focus on launching the county consumption engine in the consumption area; In terms of consumer groups, we will focus on enhancing the consumption power of low-and middle-income groups, and urge the vast number of urban and rural residents to consume, be willing to consume, and dare to consume.

Accelerate the construction of information infrastructure and build a "smart+"consumption ecosystem.

Cloud fitness, cloud shopping, cloud shopping, cloud reading … Since the outbreak, "cloud business" has developed rapidly. "Mobile phone ordering and delivery to home" has become the first choice for people to buy fresh food, medicines and other necessities during their stay at home.

"The new consumption formats and new models represented by online shopping have shown strong development potential in this epidemic." Chang Tiewei said that in 2019, the online retail sales of physical goods in China accounted for 20.70% of the total retail sales of consumer goods, which was about 8.52 trillion yuan. It is expected that the online retail sales of physical goods will exceed 10 trillion yuan this year.

"With the gradual control of the epidemic, China’s consumer market will usher in a new round of rapid development opportunities." Wei Wang, director of the Institute of Market Economy of the State Council Development Research Center, said that innovative online service models, especially in the fields of entertainment, education and medical care, have been recognized and accepted by consumers, which will greatly promote the further improvement of new formats and new models and drive more online service consumption.

The "Opinions" put forward four specific measures to cultivate new consumption formats and new models, and accelerate the construction of a "smart+"consumption ecosystem.

Accelerate the construction of a new generation of information infrastructure. Accelerate the construction and commercialization of information infrastructure such as 5G networks.

Encourage the development of new consumption patterns such as online and offline integration. Improve the "internet plus" consumption ecosystem, and promote online and offline interaction and business travel style coordination.

Encourage consumers to use green smart products. Encourage enterprises to use the Internet of Things, cloud computing, artificial intelligence and other technologies to promote the intelligent upgrade of various electronic products, and accelerate the development of new information products such as virtual reality and wearable devices.

Vigorously develop the consumption pattern of "internet plus Social Service". All departments will promote the online and offline integration of education and training, medical care, aged care services, infant care, sports events and other service consumption.

"The Opinions proposes to build a’ smart+’consumption ecosystem to adapt to the development trend of smart and online consumption at this stage. While promoting consumption expansion and quality improvement, we will better lead the industry to intelligent and green development and promote the dual upgrading of industry and consumption. " Wang Yun, a researcher at China Macroeconomic Research Institute, said.

Continuously improve consumption capacity and build a consumption network integrating urban and rural areas.

The consumption pattern is wired online and offline, and there are cities and towns in the consumption space. To improve the quality and expand the consumption, it is necessary to realize the coordinated and interactive development of the urban and rural markets. What other "hard bones" are there to break through urban and rural consumption and expand grassroots and rural consumption?

"There is still a’ stuck neck’ link in the current consumer infrastructure." Chang Tiewei said, for example, the service consumption infrastructure is not perfect, the shortcomings of consumption facilities in some emerging urban areas and rural areas are prominent, and the distribution of urban commercial facilities is unreasonable.

Wei Wang said that in order to build a consumption network integrating urban and rural areas, on the one hand, we should promote the construction and development of consumption center cities, accelerate the development of middle and high-end consumption and service consumption markets, and form a group of international consumption center cities with large consumption scale, strong consumption radiation driving effect, outstanding consumption innovation leading ability and international influence, and become a leading demonstration base for China’s consumption upgrading and expansion.

The "Opinions" propose to further improve the tax-free industry policy and improve the supply of imported goods. We will support central cities to strengthen the "first-store economy" and "first-time economy", encourage internationally renowned brands to launch or simultaneously list new products in the China market, and adjust and optimize the collection links of some consumption tax items.

"On the other hand, we should speed up the sinking of the consumer market, build a platform for cooperation and exchange between Internet companies and poverty-stricken areas, promote the two-way circulation of industrial products to the countryside and agricultural products to the city, boost the sales of agricultural products with characteristics and advantages in rural areas, especially in deep poverty-stricken areas, and better meet the consumer demand in rural markets and carry out consumption poverty alleviation in depth." Wei Wang said.

The income level of residents is directly related to their consumption ability, and the expansion and upgrading of consumption cannot be separated from the improvement of consumption ability.

"To improve the consumption power of residents, we should pay attention to improving the income capacity of middle-income groups and enhancing basic security, and promote the reform of the income distribution system." Wei Wang said, smooth the upward flow channels for low-income groups, steadily expand middle-income groups, strive to narrow the income gap among residents, and accelerate the improvement of the income incentive mechanism for knowledge-based, skilled and innovative workers. (Reporter Li Xinping)

On June 28th, BMW i4 eDrive35 was officially launched, with a price of 429,900 yuan. The appearance of the new car is equipped with an M sports suit, and the power is equipped with a battery pack with a capacity of 70 kWh. The cruising range of CLTC is 511 kilometers.

In terms of appearance, the overall shape of the new car is consistent with the eDrive40 model on sale, equipped with an M sports suit, and comes standard with personalized customized satin aluminum trim and exterior components. At the same time, i4 eDrive35 is also equipped with an 18-inch 858M dual-spoke two-color aluminum alloy rim, which is the same as i4 eDrive40. In terms of body color, the new car also continues the eDrive40 model, and comes standard with sapphire blue, mineral white, sunset orange, Portiman blue, San Remo green, Brooklyn gray and lapis lazuli red.

In terms of interior, i4 eDrive35 is also consistent with i4 eDrive40, with black, cognac and volcanic red Sensatec synthetic leather as standard. However, in terms of configuration, the keyless entry and automatic parking assistance system Plus and the BMW IconicSounds Electric electric vehicle sound wave simulation system, which are standard on the i4 eDrive40 model, have become optional on the i4 eDrive35 model, and the price has not been officially announced.

In terms of power, i4 eDrive35 is equipped with a ternary lithium battery pack with a capacity of 70 kWh and an excitation synchronous motor. The maximum output power is 210 kW, the maximum torque is 400 Nm, and the cruising range under CLTC standard is 511 km.

　　As major car companies continue to enrich the product layout of their electric vehicles, more and more car scenes have been overcome by electric vehicle products. In the past, many consumers who insisted on choosing fuel car products because of mileage anxiety, lack of driving pleasure and few options have changed their views.

　　However, it can’t be ignored that there are still a large number of consumers whose demand for cars is not limited to urban transportation. They need a car product with the functions of commuting to work and family travel during holidays. More importantly, when they swim between mountains and rivers, they don’t want to worry about finding charging piles for their cars. Then, an SUV model with exquisite shape, comfortable space, abundant power and strong off-road genes has become their first choice for car purchase. Today, the protagonist of our test drive-2024 big dog is such a product.

1. The air intake grille of the new car adopts a brand-new standard, which is more powerful with the shield-shaped middle net; The rear of the car is equipped with penetrating taillights, and the integrated design has a more holistic feeling.

2.The interior is still outstanding in science and technology, and covered with more soft materials, with fine workmanship and better touch.

3. The adjustment of the new powertrain is relatively mature, the power reserve of the 2.0T engine is strong, and the 7DCT is upgraded to 9DCT, further improving the fuel economy of the vehicle.

4. Two terrain modes (grass/gravel, concave-convex road) are added to the new model, which further improves the passability and safety and increases the driving pleasure.

　　Before officially introducing the new car, let’s briefly sort out the relationship between the new car and the big dog models currently on sale. At present, there are two generations of big dog products on the market, one is based on the annual modified model of the first generation of big dog models listed in September 2020; In addition, it is the first model listed in February this year. Although the latter is also named after the "big dog" element, the new car has adopted a new design from appearance to interior, and its size is also larger, reaching the level of medium-sized SUV. Today, the 2024 Haval Big Dog that we test drive is the latest modified model of the original Haval Big Dog.

　　The 2024 big dog basically continues the design style of the old models, which first gives people a sense of sight full of strength and wildness, and at the same time emphasizes the exquisite and fashionable design fashion through the changes of details. The front face of the 2024 big dog still adopts a relatively square outline, and the new car net has undergone a new design, showing a shield shape, which makes the new car look a little more stable and more tenacious from the front.

　　The new car headlights still use the "Eye of the Earth" round LED headlights, which are retro and highly recognizable. The outer contour of the headlight is integrated with the middle net, and the middle net is decorated with two rough horizontal silver chrome trim strips, which effectively stretches the visual width of the front of the car. The size of the brand LOGO has been increased, and the black design is adopted, which is embedded in the side trim on the middle net, which not only forms a more concise effect, but also does not lose the sense of strength.

　　The side of the new car shows the image of a typical hard-core SUV. Although the fixed side pedal is cancelled, the straight roof line, the black decorative board on the lower edge of the side door and the rounded trapezoidal wheel eyebrows like the earth fortress all imply its powerful off-road performance. The tire comes from Jiatong brand, the specification is 235/65 R18, which has both the quietness of urban driving and good off-road ability.

　　The change of new car tail is very obvious. There is no doubt that penetrating taillights are the current fashion trend. When applied to 2024 big dog models, it effectively adds a bit of luxury to this hard-core SUV. At the same time, this design also visually extends the width of the tail, echoing the front of the car.

　　There is not much innovation in the black rear bumper and the silver lower fender, but in addition to emphasizing the off-road attribute from the perception, thanks to the departure angle of 30 of the new car, the 2024 Haval Big Dog is more calm in the face of bad roads.

　　The interior of the 2024 Haval Dog maintains the same style as the old model. Two large-size LCD screens create a strong sense of science and technology in some areas, which is in sharp contrast with the armrest in front of the co-pilot who highlights the hard-core atmosphere, resulting in a kind of confrontational beauty. The center console of the new car is still made of a large number of hard plastic materials. Of course, this is understandable for a hard-core SUV that emphasizes functionality. The material of the auxiliary instrument panel of the old model is easy to leave fingerprints, and the new model has been upgraded to help keep it clean. At the same time, the center console of the new car also adopts the stitching design of stitching technology, which looks very classy.

　　It is worth mentioning that the engineers of the 2024 Haval Dog did not blindly control the cost, but effectively optimized the design method. This optimization is reflected in the fact that in addition to the leather elements used in the steering wheel and seat, the inner side of the door panel that drivers and passengers contact most often is also covered with soft materials, which makes it feel better.

　　The steering wheel of the new car has a moderate size and comfortable grip, and the multi-function button area adopts a bright black panel, which makes the physical buttons easy to operate and has a good texture.

　　The function area of the center console is designed with touch and physical buttons, which takes into account consumers with different operating habits. From the experience effect, the touch screen interface runs smoothly and the feedback is timely; Physical keys and driving mode switch knob have moderate damping and easy operation. Personally, if there is a need for functional operation during driving, physical buttons are conducive to more accurate control and more conducive to ensuring driving safety.

　　There are not many changes in the functional configuration of the 2024 Haval Dog. In fact, the models mentioned in the preceding paragraph have been perfected in this respect, such as the exterior rearview mirror with three-in-one functions of driving mode memory, heating, automatic folding and lighting, constant temperature three-zone air conditioner equipped with air purification system, and large-size panoramic sunroof.

　　What is impressive is the 360-degree panoramic image+transparent vehicle bottom function. Four wide-angle cameras are used to collect images of the environment around the vehicle, reducing the blind spots around the vehicle, enabling users to grasp the images around the vehicle in real time and improving the driving safety of the vehicle. The transparent chassis eliminates the blind area of vision through camera technology, provides the driver with the road conditions under the car, and helps the driver to see the safety hazards on the road through the display screen. The puddles and stones under the car can be cast on the screen to avoid them in time.

　　In addition, it can be seen that as an SUV model that pays attention to off-road performance, the 2024 Haval Big Dog rear axle electronically controlled mechanical jaw differential lock supports independent physical key control, realizing human-computer interaction and increasing driving pleasure; Mechanical jaw locking can realize 100% output of torque between wheels on both sides of the rear axle, and has stronger ability to get out of trouble.

　　Although the width of the seat with electric adjustment function is not large, the advantage lies in solid filling and proper support. Leather coating and stitching technology not only make the ride comfortable, but also show great grades visually. In terms of driving space, the 180CM experiencer has a punch space in his head after adjusting the seat to the appropriate position in the driver’s seat; Keeping the seat position unchanged, the experiencer also has the head space of one punch in the back row, and the leg space is close to three punches. This performance will not make passengers feel depressed even if the road is far away.

　　The 2024 Haval Big Dog continues its rich storage space. According to official information, there are as many as 37 storage spaces in the whole car, which is at the upstream level in the SUV of the same level. From the actual experience, it is more than enough to put down two bottles of 550ML drinking water in a conventional glove box, a layered central armrest box and a door panel storage compartment. The storage space under the central passage and the separate water cup holder on the door panel are not only decorative, but also convenient to use.

　　This time, my test drive vehicle adopts the powertrain of 2.0T engine +9DCT gearbox, and is equipped with intelligent four-wheel drive system. This 2.0T engine (GW4N20A) has a maximum power of 175kW and a maximum torque of 385 N m. The transmission system has been upgraded obviously, and the 7DCT gearbox used in the previous model has been replaced by the self-developed 9DCT gearbox. A more compact speed ratio will help to improve the smoothness and comfort of shifting, as well as the low-speed power and high-speed economy.

　　Driving: driving in the city is safe, and long-distance cross-country is more fun to control.

　　Although this 2.0T engine has a good book strength, we can clearly feel its pursuit of comfort in actual driving. The accelerator pedal feedback of a new car is definitely not sensitive. At the beginning of the pedal stroke, it corresponds to a linear power output, and the momentum is not obvious, and the shift process is also very smooth. If you want to get a simple sense of acceleration in the initial stage, don’t hesitate to step on the accelerator pedal deeply. The powerful power reserve will be output violently when the accelerator pedal stroke is close to about one third.

　　With the increase of vehicle speed, the power supply of new cars becomes more abundant, which also brings full confidence to drivers in overtaking at high speed. At this point, the throttle feedback is also positive, which can be said to be on call. At the same time, it is not difficult to find that thanks to the wider gear ratio of the gearbox, under the same speed, the speed of the 2024 Haval Big Dog is lower than that of the previous model, which undoubtedly helps to improve the fuel economy of the vehicle.

　　However, it should be noted that the steering system of the new car needs to be adapted more, especially in the middle and high speed range, and it can be clearly felt that there is a certain virtual amount in the steering wheel. If the comfort of passengers in the car is to be guaranteed, the timing of braking should be grasped before entering the corner, and the speed should be lowered as soon as possible. Of course, this is not to say that the bending safety is insufficient, but to avoid giving passengers the feeling that the lateral support is too soft.

　　As another important upgrade of the 2024 Haval Big Dog, the new car has added two terrain modes: bumpy road, grass/gravel, based on the driving modes of economy, standard, sports, mud, sand and snow. As we all know, bumpy roads make it difficult for vehicles to pass. The all-terrain control system of 2024 Haval Dog will control the slip of the vehicle through the vehicle stability system control unit and differential lock to improve the passing ability of the vehicle.

　　In this test drive, we actually experienced the grass road conditions. Usually, vehicles are easy to slip in this scene, and the stability and passability are poor. With the blessing of the all-terrain system, the 2024 Haval Big Dog can easily drive on the wet grass by controlling the entire chassis electronic control system of the vehicle.

　　In addition to the further subdivision of driving mode, the 2024 big dog can perform well in this unpaved road condition thanks to the intelligent four-wheel drive system adopted. In AUTO mode, the electronically controlled hydraulic active control system distributes the torque of the front and rear axles more quickly, accurately and smoothly. In the face of complex and changeable road conditions, the intelligent and dynamic torque distribution characteristics respond instantaneously with the change of vehicle working conditions, which greatly improves the driving comfort and flexibility of vehicles.

　　Summary: Since its launch in 2020, Haval Dog, as a online celebrity model in China SUV market, has become a travel companion for more than 300,000 car users. Although the appearance of the 2024 Haval Big Dog has not changed much, it has brought obvious texture upgrade. The interior is still outstanding in science and technology, and the addition of some soft materials better guarantees the driving comfort. The adjustment of the new powertrain is relatively mature, the power reserve of the 2.0T engine is strong, the 7DCT is upgraded to 9DCT, and the denser gear ratio obviously improves the smoothness of shifting. The newly added driving mode also performed well, further optimizing the passing capacity of the new car under complex working conditions.

　　It is understood that 2024 big dogs will be listed in the near future. In addition to the 2.0T+9DCT model we have tested this time, we will also launch a model equipped with a 1.5GDIT engine (GW4B15L)+7DCT transmission power combination. The maximum power of the 1.5T engine is 135kW, and the peak torque of generate is 275N·m at 1500rpm. The comprehensive transmission efficiency of 7DCT transmission reaches 95.6%, reaching the functional safety level of ASIL-C system. Combined with the pricing strategy of current models, I believe that the 2024 Haval Big Dog will once again enhance its cost-effective advantage and take the lead in the cruel market game.